Compare Strategy Inc. (MSTR) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Strategy Inc. vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Strategy Inc. trades at $154.08 (market cap $60.40B), while Nuvation Bio Inc. Class A Common Stock trades at $4.98 (market cap $1.74B). The key difference: Strategy Inc. is far larger — about 34.7× Nuvation Bio Inc. Class A Common Stock's market cap, and Strategy Inc. is more actively traded (23,421,830 versus 9,289,619). Which is the better fit depends on your goals — on Pluang, investors hold Strategy Inc. for 112 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| MSTR | NUVB | |
|---|---|---|
Market Cap | $60.40B | $1.74B |
Volume | 23,421,830 | 9,289,619 |
Sector | Technology | Health |
52-Week High | $320.29 | $9.54 |
52-Week Low | $82.31 | $3.41 |
Typical Hold Time | 112 Days | 0 Days |
Enterprise Value | $79.16B | $1.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSTR stock trades at $153.37, down 6.79% today, reflecting volatility despite a bullish technical signal. The company reported a net loss of $3.85B in 2025 with a negative net income margin of -6,102.96%, though revenue grew slightly to $477.23M. Analyst consensus remains optimistic with a $252 price target, but earnings misses in recent quarters highlight operational challenges.
The outlook hinges on improving profitability and Bitcoin market stability, offering upside if earnings rebound. Key risks include persistent losses, high debt, and sensitivity to macroeconomic factors. Investors should weigh analyst optimism against fundamental weaknesses before considering a position.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
